Cyclacel Pharmaceuticals, Inc. (CYCC) NASDAQ

6.37

-0.405(-5.98%)

Updated at September 11 04:00PM

Currency In USD

Valuation

Market Cap749.48M
Enterprise Value746.34M
P/E Ratio-1.57
PEG Ratio-0.14
Price/Sales Ratio-424.33
Price/Book Ratio2,776.63
Enterprise/Revenue-424.56
Enterprise/EBITDA-1.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin256.32
Operating Margin414.32

Management Effectiveness

Return On Assets-1,456.03
Return On Equity327.07

Income Statement

Revenue43,000
Revenue/Share-0.02
Gross Profit43,000
EBITDA-12M
Net Income-11.21M
Diluted EPS-1.36

Balance Sheet

Total Cash4,275
Total Cash/Share0
Total Debt10,000
Total Debt/Equity2.75
Current Ratio5.77
Book Value Per Share0

Price History

52-Week Change-96.68
52-Week High597.6
52-Week Low3.08
Moving Average 50 Days8.11
Moving Average 200 Days44.19

Statistics

Average Volume1.81M
Shares Outstanding1.67M
% Held by Institutions0.23

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield2.36
Payout Ratio-0
Last Split Factor1:15
Last Split DateJuly 07, 2025